NIDDK
-
August 8, 2017
Early drivers of gastric cancer
Using bioinformatics approaches, Vanderbilt investigators have identified gene expression networks that are deregulated in mouse and human stomach cancers. -
August 3, 2017
HDAC3 role in B-cell development
The histone deacetylase HDAC3 is required for the maturation of B cells, white blood cells that produce antibodies. -
June 15, 2017
VUMC team’s discovery could lead to new diabetes treatment
-
June 14, 2017
PET imaging to predict tumor response
A PET probe that detects the amino acid glutamine predicts whether tumors respond to certain targeted therapies in preclinical animal models. -
June 9, 2017
Flip side of gut protection
Vanderbilt investigators report that dysregulation of certain immune cells in the intestines may lead to inflammation and disease. -
June 8, 2017
NIDDK renews Vanderbilt’s diabetes research grant
The Vanderbilt Diabetes Research and Training Center (VDRTC) is celebrating its 44th year of operation with a five-year competitive renewal of its $9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH). -
May 11, 2017
EETs contribute to insulin sensitivity
Interventions that increase circulating levels of compounds called EETs may improve insulin sensitivity and treat hypertension.